ZyVersa Therapeutics, Inc.(ZVSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZVSA ZyVersa Therapeutics, Inc.

已收盘 03-24 16:00:00 EDT 延时

{"stockData":{"symbol":"ZVSA","market":"US","secType":"STK","nameCN":"ZyVersa Therapeutics, Inc.","latestPrice":0.22,"timestamp":1774382400000,"preClose":0.222,"halted":0,"volume":10113,"delay":15,"changeRate":-0.009009009009009018,"floatShares":7673206,"shares":8095921,"eps":-4.68,"marketStatus":"已收盘","change":-0.002,"latestTime":"03-24 16:00:00 EDT 延时","open":0.222,"high":0.241,"low":0.22,"amount":2241.6840500000003,"amplitude":0.094595,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-4.68,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":5,"adr":0,"exchange":"OTCQB","adjPreClose":0.222,"volumeRatio":0.64483},"requestUrl":"/m/hq/s/ZVSA","defaultTab":"news","newsList":[{"id":"2518274980","title":"Zyversa Therapeutics, Inc.盘中异动 早盘股价大跌6.12%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518274980?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:32","pubTimestamp":1741620739,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时32分，Zyversa Therapeutics, Inc.股票出现异动，股价大幅跳水6.12%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3620.33%、1620.34%、805.74%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为67.94%、49.87%、41.36%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310233219a26a522b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310233219a26a522b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2517191068","title":"Zyversa Therapeutics, Inc.盘中异动 大幅下跌7.50%报0.999美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517191068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517191068?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185077,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Zyversa Therapeutics, Inc.股票出现异动，股价快速下跌7.50%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223117a260c714&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223117a260c714&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2514348860","title":"Zyversa Therapeutics, Inc.盘中异动 急速拉升5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514348860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514348860?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:48","pubTimestamp":1740602892,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时48分，Zyversa Therapeutics, Inc.股票出现异动，股价急速拉升5.50%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270448129893ee10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270448129893ee10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZVSA","LENZ"],"gpt_icon":0},{"id":"2514770659","title":"Zyversa Therapeutics, Inc.盘中异动 急速下跌6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514770659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514770659?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:06","pubTimestamp":1740423992,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时06分，Zyversa Therapeutics, Inc.股票出现波动，股价快速下跌6.55%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为320.04%、135.25%、39.77%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225030633a2524ebc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225030633a2524ebc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2512171483","title":"Zyversa Therapeutics, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512171483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512171483?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:30","pubTimestamp":1739975444,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时30分，Zyversa Therapeutics, Inc.股票出现波动，股价大幅下跌5.04%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Cellectar Biosciences, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为201.54%、200.70%、65.18%，振幅较大的相关个股有Azitra Inc、Cellectar Biosciences, Inc.、Alzamend Neuro, Inc.，振幅分别为11.29%、6.05%、3.70%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192230449628ccf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192230449628ccf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZVSA","LENZ"],"gpt_icon":0},{"id":"2508145705","title":"Zyversa Therapeutics, Inc.盘中异动 早盘快速下跌6.62%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508145705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508145705?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:39","pubTimestamp":1738679949,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时39分，Zyversa Therapeutics, Inc.股票出现波动，股价急速下挫6.62%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1080.70%、743.04%、193.51%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Azitra Inc、Invivyd, Inc.，振幅分别为40.00%、38.71%、21.70%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042239099617d8ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042239099617d8ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVSA","BK4139"],"gpt_icon":0},{"id":"2506630321","title":"Zyversa Therapeutics, Inc.盘中异动 早盘股价大跌6.13%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506630321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506630321?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:41","pubTimestamp":1737988890,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时41分，Zyversa Therapeutics, Inc.股票出现异动，股价急速下跌6.13%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224130a2316d16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224130a2316d16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ZVSA"],"gpt_icon":0},{"id":"2505811274","title":"Zyversa Therapeutics, Inc.盘中异动 股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505811274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505811274?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:33","pubTimestamp":1737469991,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时33分，Zyversa Therapeutics, Inc.股票出现波动，股价快速上涨5.60%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223312986e3337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223312986e3337&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2504162133","title":"Zyversa Therapeutics, Inc.盘中异动 股价大涨5.93%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504162133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504162133?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:33","pubTimestamp":1737124391,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时33分，Zyversa Therapeutics, Inc.股票出现波动，股价大幅上涨5.93%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223311a225bc52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223311a225bc52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ZVSA"],"gpt_icon":0},{"id":"2492104179","title":"Zyversa Therapeutics, Inc.盘中异动 早盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492104179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492104179?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:35","pubTimestamp":1734618902,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时35分，Zyversa Therapeutics, Inc.股票出现异动，股价快速上涨5.00%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.38%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223503ab849fb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223503ab849fb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","BK4139","LENZ"],"gpt_icon":0},{"id":"2490323043","title":"Zyversa Therapeutics, Inc.盘中异动 早盘急速上涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490323043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490323043?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:50","pubTimestamp":1733845803,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时50分，Zyversa Therapeutics, Inc.股票出现异动，股价急速拉升5.65%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1933.46%、448.19%、138.38%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Uniqure N.V.，振幅分别为154.91%、131.78%、44.00%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023500395e8b255&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023500395e8b255&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2488553670","title":"Zyversa Therapeutics, Inc.盘中异动 早盘快速下挫5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488553670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488553670?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:10","pubTimestamp":1733152205,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时10分，Zyversa Therapeutics, Inc.股票出现波动，股价急速跳水5.95%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202231005abf015ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202231005abf015ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ZVSA"],"gpt_icon":0},{"id":"2485267995","title":"Zyversa Therapeutics, Inc.盘中异动 早盘股价大跌5.26%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485267995?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:21","pubTimestamp":1732288919,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时21分，Zyversa Therapeutics, Inc.股票出现波动，股价快速下挫5.26%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122232159a24e37fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122232159a24e37fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2484635675","title":"Zyversa Therapeutics, Inc.盘中异动 股价大涨9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484635675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484635675?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940272,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Zyversa Therapeutics, Inc.股票出现异动，股价快速上涨9.26%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822311295be4810&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822311295be4810&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","BK4139","LENZ"],"gpt_icon":0},{"id":"2481104309","title":"Zyversa Therapeutics, Inc.盘中异动 早盘股价大涨5.26%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481104309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481104309?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:33","pubTimestamp":1731076422,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时33分，Zyversa Therapeutics, Inc.股票出现异动，股价快速上涨5.26%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223343abae3d69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223343abae3d69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2474228332","title":"Zyversa Therapeutics, Inc.盘中异动 早盘急速下跌6.41%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474228332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474228332?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:32","pubTimestamp":1728484338,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时32分，Zyversa Therapeutics, Inc.股票出现波动，股价急速下跌6.41%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009223218ab68df68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009223218ab68df68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2469494393","title":"Zyversa Therapeutics, Inc.盘中异动 早盘大幅上涨5.56%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469494393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469494393?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:45","pubTimestamp":1727185508,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时45分，Zyversa Therapeutics, Inc.股票出现异动，股价快速上涨5.56%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Seelos Therapeutics, Inc.、Onconetix, Inc.、Wave Life Sciences Ltd.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为1449.11%、154.69%、30.17%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Onconetix, Inc.、Capricor Therapeutics, Inc.，振幅分别为59.63%、41.71%、28.22%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092421450898e38a84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092421450898e38a84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ZVSA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zyversa.com","description":"ZyVersa Therapeutics, Inc.于2021年3月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，利用专有技术为具有高度未满足医疗需求的慢性肾病或炎症性疾病患者开发药物。","exchange":"OTCQB","name":"ZyVersa Therapeutics, Inc.","nameEN":"ZyVersa Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ZyVersa Therapeutics, Inc.(ZVSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ZyVersa Therapeutics, Inc.(ZVSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ZyVersa Therapeutics, Inc.,ZVSA,ZyVersa Therapeutics, Inc.股票,ZyVersa Therapeutics, Inc.股票老虎,ZyVersa Therapeutics, Inc.股票老虎国际,ZyVersa Therapeutics, Inc.行情,ZyVersa Therapeutics, Inc.股票行情,ZyVersa Therapeutics, Inc.股价,ZyVersa Therapeutics, Inc.股市,ZyVersa Therapeutics, Inc.股票价格,ZyVersa Therapeutics, Inc.股票交易,ZyVersa Therapeutics, Inc.股票购买,ZyVersa Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ZyVersa Therapeutics, Inc.(ZVSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ZyVersa Therapeutics, Inc.(ZVSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}